Research in advance for FMD novel vaccines

Virology Journal

Volumn 8, Issue , 2011, Pages

  Zhang, Liang ^a   Zhang, Jie ^a   Chen, Hao Tai ^a   Zhou, Jian Hua ^a   Ma, Li Na ^a   Ding, Yao Zhong ^a   Liu, Yong Sheng ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CAPSID PROTEIN; DNA FRAGMENT; FOOT AND MOUTH DISEASE VACCINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 9; LIVE VACCINE; NEUTRALIZING ANTIBODY; PEPTIDE VACCINE; PROTEIN VP1; SUBUNIT VACCINE; VIRUS ANTIGEN; INACTIVATED VACCINE; VIRUS VACCINE;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG EFFICACY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; NONHUMAN; REVIEW; SINGLE DRUG DOSE; TREATMENT RESPONSE; VACCINE PRODUCTION; VIRION; VIRUS CAPSID; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MEDICAL RESEARCH;

ANIMALIA;

ANIMALS; BIOMEDICAL RESEARCH; FOOT-AND-MOUTH DISEASE; IMMUNOLOGIC MEMORY; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 79957793359     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-268     Document Type: Review

References (62)

1. Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America, combining expert opinion, official disease information and livestock populations to assist risk assessment. K Sumption M Rweyemamu W Wint, Transboundary and Emerging Diseases 2008 55 1 5 13 10.1111/j.1865-1682.2007. 01017.x 18397505
2. The foot-and-mouth disease epidemic of 2001 in the UK: implications for the USA and the "war on terror". P Gibbs, Journal of Veterinary Medical Education 2003 30 Summer 2 121 32 12970855 (Pubitemid 36961611)
3. Psychosocial effects of the 2001 UK foot and mouth disease epidemic in a rural population: qualitative diary based study. M Mort I Convery J Baxter C Bailey, BMJ (Clinical Research Ed) 2005 331 7527 1234 10.1136/bmj.38603.375856. 68 (Pubitemid 41713194)
4. FMD vaccines. TR Doel, Virus Research 2003 91 1 81 99 10.1016/S0168-1702(02)00261-7 12527439 (Pubitemid 36078432)
5. Foot and mouth disease virus vaccines. Luis L Rodriguez Marvin J Grubman, Vaccine 2009 27 90 D94 19837296
6. The structure of foot-and-mouth disease virus protein. J Laporte, J Gen Virol 1969 4 4 631 634 10.1099/0022-1317-4-4-631 4308493
7. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection. DJ Rowlands DV Sangar F Brown, J Gen Virol 1971 13 1 85 93 10.1099/0022-1317-13-1-85 4331815
8. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. HL Bachrach DM Moore PD McKercher J Polatnick, Journal of Immunology 1975 115 6 1636 1641
9. Cloning of cDNA of major antigen of foot-and-mouth disease virus and expression in E.coli. Hans Küpper Walter Keller Christina Kurz Sonja Forss Heinz Schaller Reinhard Franze Karl Strohmaier Otfried Marquardt Vladimir G Zaslavsky Peter Hans Hofschneider, Nature 1981 289 555 559 10.1038/289555a0 6258084 (Pubitemid 11143147)
10. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. DG Kleid D Yansura B Small D Dowbenko DM Moore MJ Grubman PD McKercher DO Morgan BH Robertson HL Bachrach, Science 1981 214 1125 1129 10.1126/science.6272395 6272395 (Pubitemid 12176624)
11. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris. V Balamurugan R Renji SN Saha GR Reddy S Gopalakrishna VVS Suryanarayana, Arch Virol 2005 19 1 513 516
12. Expressions of bovine IFN-and foot-and-mouth disease VP1 antigen in P. pastoris and their effects on mouse immune response to FMD antigens. XJ Shi B Wang C Zhang M Wang, Vaccine 2006 24 82 89 10.1016/j.vaccine.2005.07.051 16135391 (Pubitemid 41721103)
13. Protection conferred by TrpE fusion proteins containing portions of the C -terminal region of capsid protein VP1 of foot -and -mouth disease virus. Giavedoni D Luis Kaplan Gerardo Marcovecchio Felipe Maria Elisa Piccone Eduardo L Palma, Journal of General Virology 1991 72 967 971 10.1099/0022-1317-72-4-967 1849980
14. Recombinant Vaccine Containing Both B Cell and T Cell Epitopes Induces Guinea Pig in Immune Responses Against Type O Foot-and-Mouth Disease Virus. jun Yang Zhi Yan Lin jin LiI Guang yao Yan Wei xing Xu Quan jin You Yong xing Zheng Zhao, Journal of Fudan University 2000 39 5 564 568
15. The immune responses of the fusion protein including two copies of T cell and B cell epitopes of Food-and-mouth disease VP1. Zhuang Juan Cao Xiang-rong Cheng bo Rao Zhong Pan Jie Xu Quan-xing You Yong-jin, Chinese Journal of Preventive Veterinary Medicine 2005 27 6 494 503
16. Stability and immunogenicity of empty particles of foot-and-mouth disease virus. MM Rweyemamu G Terry TW Pay, Archives of Virology 1979 59 1-2 69 79 10.1007/BF01317896 218538 (Pubitemid 9100534)
17. Screening and stability of Madin-Darby bovine kidney cell strain co-expressing the capsid precursor protein P1-2A gene and the protease 3C gene of foot-and-mouth disease virus. J Li Y L iu X Liu,, et al. Acta Microbiologica Sinica 2008 48 11 1520 1525 19149169
18. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. MJ Grubman, Biologicals 2005 33 227 234 10.1016/j.biologicals.2005.08.009 16289996 (Pubitemid 41743812)
19. Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones. Wu Sau-Ching Ye Ruiqiong Wu Xu-Chu Ng Shi-Chung Wong Sui-Lam, Bacteriol 1998 180 11 2830 2835
20. Development of fungal nd algal cells for expression of foreign genes. WC Leung EK Manavathu J Zavaagstra K Surunaraynan, Applied Virology Academic Press New York 1986 25 30
21. Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. SK Tikoo DR Fitzpatrick LA Babiuk TJ Zamb, J Virol 1990 64 10 5132 5142 2168991 (Pubitemid 20329836)
22. Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type 'O' produced in Pichia pastoris. V Balamurugan R Renji SN Saha GR Reddy S Gopalakrishna VV Suryanarayana, Virus Research 2003 92 2003 141 149 12686422 (Pubitemid 36398458)
23. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. Li Zhiyong Yi Yongzhu Yin Xiangping Zhang Zhifang Liu Jixing, PLoS One 2008 3 5 2273 10.1371/journal.pone.0002273 18509464
24. A replication defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. ZQ Xiang Y Yang JM Wilson HC Ertl, Virology 1996 219 220 227 10.1006/viro.1996.0239 8623532 (Pubitemid 26180398)
25. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. V Juillard P Villefroy D Godfrin A Pavirani A Venet JG Guillet, Eur J Immunol 1995 25 3467 3473 10.1002/eji.1830251239 8566039 (Pubitemid 26004956)
26. Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents. AR Fooks D Jeevarajah J Lee A Warnes S Niewiesk V ter Meulen JR Stephenson JC Clegg, J Gen Virol 1998 79 1027 1031 9603317 (Pubitemid 28203843)
27. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide(P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. A Sanz-Parra MA Jimenez-Clavero MM Garc-a-Briones E Blanco F Sobrino V Ley, Virology 1999 259 129 134 10.1006/viro.1999.9717 10364496 (Pubitemid 29391762)
28. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. GA Mayr J Chinsangaram MJ Grubman, Virology 1999 263 2 496 506 10.1006/viro.1999.9940 10544121 (Pubitemid 29521540)
29. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. MP Moraes GA Mayr PW Mason MJ Grubman, Vaccine 2002 20 11-12 1631 1639 10.1016/S0264-410X(01)00483-2 11858872 (Pubitemid 34169805)
30. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. JM Pacheco MC Brum MP Moraes WT Golde MJ Grubman, Virology 2005 337 2 205 209 10.1016/j.virol.2005.04.014 15893355 (Pubitemid 40798988)
31. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease. Z Lu H Bao Y Cao P Sun J Guo P Li X Bai Y Chen B Xie D Li Z Liu Q Xie, Vaccine 2008 26 48 G53 19178894
32. Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. A Berinstein C Tami O Taboga E Smitsaart E Carrillo, Vaccine 2000 18 2231 2238 10.1016/S0264-410X(99)00561-7 10717342 (Pubitemid 30136362)
33. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3c protease coding regions of foot-and-mouth disease virus. M Zheng N Jin H Zhang M Jin H Lu M Ma C Li G Yin R Wang Q Liu, J Virol Methods 2006 136 230 237 10.1016/j.jviromet.2006.05.019 16780963 (Pubitemid 44051598)
34. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs. Q Yao P Qian Q Huang Y Cao H Chen, J Virol Methods 2008 147 1 143 150 10.1016/j.jviromet.2007.08.027 17963851 (Pubitemid 350258576)
35. Effects of chronic heat stress on immune responses of the foot-and-mouth disease DNA vaccination. Y Hu H Jin X Du C Xiao D Luo B Wang R She, DNA Cell Biol 2007 26 8 619 26 10.1089/dna.2007.0581 17688414 (Pubitemid 47263209)
36. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. HT Wong SCS Cheng EWC Chan ZT Sheng WY Yan ZX Zheng Y Xie, Virology 2000 278 1 27 35 10.1006/viro.2000.0607 11112477 (Pubitemid 32002590)
37. Gene gun-mediate DNA vaccination against foot-and- mouth disease virus. L Benvenisti A Rogel L Kuznetzova S Bujanover Y Becker Y Stram, Vaccine 2001 19 3885 3895 10.1016/S0264-410X(01)00125-6 11427262 (Pubitemid 32566311)
38. DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease. HJ Shao L Chen YB Su, Vet Res Commun 2005 29 1 35 46 16244922 (Pubitemid 39480647)
39. Optimization strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2. Zhang Hong-Ying Sun Shu-Han Guo Ying-Jun Zhu Wei-Jia Shi Ke Xu Gen-Xing Wang Jian-Jun, Vaccine 2008 26 6 769 77 10.1016/j.vaccine.2007.11.093 18191307
40. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination. B Su J Wang X Wang H Jin G Zhao Z Ding Y Kang B Wang, Vaccine 2008 26 40 5111 22 10.1016/j.vaccine.2008.03.089 18462845
41. Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct. Zou Qiang Wu Bing He Xiaodan Zhang Yizhi Kang Youmin Jin Jin Xu Hanqian Liu Hu Wang Bin, J Biomed Biotechnol 2010 2010 Article ID 562356
42. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Wang Xiao Zhang Xinyu Kang Youming Jin Huali Du Xiaogang Zhao Gan Yu Yang Li Jinyao Su Baowei Huang Chang Wang Bin, Vaccine 2008 26 40 5135 44 10.1016/j.vaccine.2008.03.088 18462848
43. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18. M Ma N Jin G Shen G Zhu HJ Liu M Zheng H Lu X Huo M Jin G Yin H Ma X Li Y Ji K Jin, Vet Immunol Immunopathol 2008 121 1-2 1 7 10.1016/j.vetimm.2007.06.029 17706296 (Pubitemid 350235644)
44. Enhancing immune responses against a plasmid DNA vaccine encoding FMDV empty capid from serotype O. Y Li N Aggarwal HH Takamatsu CM Sterling C Voyce PV Barnett, Vaccine 2006 24 4602 4606 10.1016/j.vaccine.2005.08.032 16154238 (Pubitemid 43776757)
45. Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV. E Rieder B Baxt J Lubroth PW Mason, J Virol 1994 68 11 7092 7098 7523697 (Pubitemid 24328760)
46. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. TS McKenna J Lubroth E Rieder B Baxt PW Mason, J Virol 1995 69 9 5787 5790 7637023
47. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. ME Piccone E Rieder PW Mason MJ Grubman, J Virol 1995 69 9 5376 5382 7636982
48. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. J Chinsangaram PW Mason MJ Grubman, Vaccine 1998 16 16 1516 1522 10.1016/S0264-410X(98)00029-2 9711798 (Pubitemid 28366087)
49. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. PW Mason ME Piccone TS Mckenna J Chinsangaram MJ Grubman, Virology 1997 227 1 96 102 10.1006/viro.1996.8309 9007062 (Pubitemid 27241058)
50. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. T de Los Santos S de Avila Botton R Weiblen MJ Grubman, J Virol 2006 80 4 1906 14 10.1128/JVI.80.4.1906-1914.2006 16439546 (Pubitemid 43228730)
51. Antibodies against a preselected peptide recognise and neutralise foot and mouth disease virus. E Pfaff M Mussgay HO Bohm GE Schulz H Schaller, EMBO J 1982 17 869 874
52. The three dimensional structure of foot-and-mouth disease virus at 2.9 resolution. R Acharya E Fry D Stuart G Fox D Rowlands F Brown, Nature 1989 337 6209 709 16 10.1038/337709a0 2537470 (Pubitemid 19064726)
53. Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the viral nucleotide sequence. James L Bittle Richard A Houghten Alexander Hannah Thomas M Shinnick J Gregor Sutcliffe Richard A Lerner David J Rowlands Brown Fred, Nature 1982 298 30 33 10.1038/298030a0 7045684 (Pubitemid 12087468)
54. Protection of cattle against foot-and-mouth disease by a synthetic peptide. R DiMarchi G Brooke C Gale V Cracknell T Doel N Mowat, Science 1986 232 639 641 10.1126/science.3008333 3008333 (Pubitemid 16061973)
55. New approaches to vaccination against foot-and-mouth disease. F Brown, Vaccine 1992 1014 1022 1026
56. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. O Taboga C Tami E Carrillo JI Nú̃ez A Rodríguez JC Saíz E Blanco ML Valero X Roig JA Camarero D Andreu MG Mateu E Giralt E Domingo F Sobrino EL Palma, J Virol 1997 714 2606 2614 (Pubitemid 27119896)
57. Association of Bovine DRB3 Alleles with immune response to FMDV peptides and protection against viral challenge. MM García-Briones GC Russell RA Oliver C Tami O Taboga E Carrillo EL Palma F Sobrino EJ Glass, Vaccine 2001 19 1167 1171 (Pubitemid 32008283)
58. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T cell determinants. MJ Francis GZ Hastings AD Syred B McGinn F Brown DJ Rowlands, Nature 1987 330 168 170 10.1038/330168a0 2444892 (Pubitemid 17158545)
59. Synthetic peptide vaccines: success at last. RH Meloen JI Casal K Dalsgaard JPM Langeveld, Vaccine 1995 1310 885 886
60. High-affinity antibody induced by immunisation with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. MW Steward CM Stanley R DiMarchi G Mulcahy TR Doel, Immunology 1991 721 99 103
61. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. CY Wang TY Chang AM Walfield J Ye M Shen SP Chen MC Li YL Lin MH Jong PC Yang N Chyr E Kramer F Brown, Vaccine 2002 20 2603 2610 10.1016/S0264-410X(02)00148-2 12057619 (Pubitemid 34615602)
62. Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric Peptide. Carolina Cubillos Beatriz G de la Torre Annamaria Jakab Giorgia Clementi Eva Borra's Juan Ba'rcena David Andreu Francisco Sobrino Esther Blanco, J Virol 2008 82 7223 7230 10.1128/JVI.00401-08 18448530 (Pubitemid 351977739)